Corneal graft outcome was assessed within a large, prospectively collected datahase of 4499 records. Penetrating corneal graft survival was 91% at 1 year, 72% at 5 years and 69% at 7 years. The three most common indications for graft were keratoconus (30%), bullous keratopathy (25%) and failed previous graft (18%); the three most common causes of graft failure were rejection (34%), infection (18%) and glaucoma (9%). The vast majority of grafts were performed for improved visual acuity. About four-fifths of recipients achieved at least one line of better acuity on the Snellen chart post-operatively; of the remainder with unchanged or worse acuity, only 21% had failed grafts. Overall, 43% of recipients achieved a best corrected Snellen acuity of 6/12 or better, 52% achieved 6/18 or better, and 20% had acuitities of less than 6/60.
time-point post-operatively should a given measure be applied? Third, some consideration needs to be given to an assessment of whether a given outcome is actually amenable to change by expert intervention.
Clearly, any discussion of outcomes is best anchored in baseline data, one source of which is the general case register. Research databases provide information that is qualitatively and quantitatively different from the data that accrue from clinical trials and the two approaches are complementary. A data base allows long-term and continuing assessment of current outcomes, which in turn may provide the impetus for clinical trials. Here, we examine factors affecting corneal graft and visual outcome within such a large register, to try to address the question of the success of corneal transplantation.
PATIENTS AND METHODS
The register operates within the guidelines of the institutional Committee on Clinical Investigations. No experimentation on human subjects is involved. Entry and follow-up of corneal graft recipients into the register and statistical analyses were described elsewhere. 1 • 2 In brief, data were mailed to the Registry by the contributing surgeon as soon as possible after the graft and follow-up information was requested at approximately yearly intervals. Missing data were routinely sought by follow-up letter. Each graft was followed until graft failure or until the death or loss to follow-up of the patient. Snellen acuities and keratome try readings were compared using the Mann-Whitney U-test, adjusted for ties (Minitab v8, Minitab Inc., State College, PA, USA). Kaplan-Meier survival functions were pre pared using SPIDA (Statistical Laboratory, Mac quarie University, NSW, Australia).
Prospectively collected data entered by
Eye (1995) 9, 219-227 © 1995 Royal College of Ophthalmologists approximately 300 contributors were available on 6031 penetrating corneal grafts, 4499 (75%) of which had been followed. Minimum trial time was 1 day (representing primary non-functions), maximum trial time was 7.7 years; 170 recipients (4% of those followed) had died and 504 (11 %) had been lost to follow-up. Presenting diseases, indications for graft, post operative complications and reasons for graft failure were coded using the ICD.9.CM system (US Department of Health and Human Services). The intraocular pressure (lOP) was generally considered to be significantly raised if a reading of 25 mmHg or greater was made by applanation tonometry, but the decision was at the discretion of the ophthalmologist. Primary graft non-functions were defined as grafts that never thinned and cleared in the post-operative period. The trial time for such grafts was arbitrarily adjusted to 1 day. Any existing graft that was replaced by another in the same eye, irrespective of graft clarity and for whatever reason, was classified as a failed graft. In other cases, graft failure was defined as oedema and irremediable loss of clarity in a previously thin, clear graft. The day of failure was the first day the patient was seen with an oedema tous, opaque graft that subsequently failed to thin and clear. Rejection was defined as the development of a rejection line (epithelial or endothelial) or a unilateral anterior chamber reaction with corneal infiltrates and spreading corneal oedema in a previously thin, clear graft. Any development with the potential to compromise graft outcome was considered to be a complication. Information was specifically sought on complications including exposed sutures, stitch abscess, breakage/premature loosening of graft suture, retained suture material, wound dehiscence, neovascularisation of the graft, synechiae, uveitis, rise in lOP, fixed dilated pupil, cataract, rejection episode, microbial keratitis, her petic recurrence, early changes of bullous kerato pathy, refractive and related errors, and factors potentially affecting visual outcome but unrelated to the graft (including cataract, aphakia, amblyopia, retinal detachment, cystoid macular oedema and senile macular degeneration). Contributors were asked to specify any other relevant complications, information or departures from their preferred treatment, and operative procedures on the grafted eye including refractive surgery. They also provided data on refraction, acuity and lens status.
For Kaplan-Meier survival curves, 3 -5 trial time was calculated as the number of days between the date of graft and the date on which the patient was last seen. For failed grafts, trial time was calculated as the number of days between the date of graft and the date of failure. Cox proportional hazards regression was used to investigate associations
between potential risk factors and the risk of graft failure. 6
RESULTS

Overall Graft Survival
Overall Kaplan-Meier survival of penetrating grafts followed within the ACGR is shown in Fig. 1 . Graft survival at 1, 3, 5 and 7 years was 91 %, 79%, 72% and 69%, respectively. The major indications for graft were keratoconus (30%), pseudophakic and aphakic bullous keratopathy (25%), failed previous graft (18%), corneal scars and opacities (11 %) and corneal dystrophies (7%). Major reasons for the 640 cases of graft failure are listed in Table I : irreversible rejection was the most important cause of graft failure, followed by infective complications (includ ing herpetic recurrences) and glaucoma. It is noteworthy that in 194 cases (30%), the reasons for graft failure were considered to be multifactorial. An earlier study 2 encompassing about half the grafts that have now been followed showed near-identical indications for graft and major reasons for failure, suggestive of a reasonably stable pattern of practice over some years. Analysis of Cox proportional hazards regression of factors influencing graft out come at the earlier time indicated that wound dehiscence, a rise in lOP after graft, inflammation at the time of graft, an indication for graft that was not keratoconus or a corneal dystrophy, a history of previous graft in the ipsilateral eye, a graft size outside the range of 7.0-7.9 mm diameter, and the Post-operative astigmatism as measured by keratometry at most recent follow-up for penetrating corneal grafts. K readings were available for 27% of those grafts followed. TRIAL TIME (YEARS POST-GRAFT) TRIAL TIME (YEARS POST-GRAFT) (b) TRIAL TIME (YEARS POST-GRAFT)
PROBABILITY OF GRAFT SURVIVAL
Number at Risk presence of an anterior chamber intraocular lens or aphakia in the grafted eye were independent risk factors for graft failure?
Visual Outcome Snellen Acuity and Astigmatism Post-graft. Snellen acuities for the whole cohort with follow-up are shown in Fig. 2 ; the pattern did not alter noticeably when only grafts followed for longer than 2 years were examined (data not shown). Overall, 43% of recipients achieved a best corrected Snellen acuity of 6/12 or better, 52% achieved 6/18 or better, and 20% had acuities of less than 6/60. Significant anisome tropia was listed as a problem in 1 % of recipients. Reasons for poor post-operative acuity (recorded as less than 6160) are shown in Table II : as might have been anticipated, graft failures and other complica tions of the graft accounted for about 50% of cases, but a substantial proportion (over 40%) of recipients had a co-morbidity in the grafted eye that reduced the visual potential of that eye. Post-operative astigmatism as measured by kera tometry is shown in Fig. 3 . Keratometry readings were available for 1232 grafts (27% of those followed); the median post-graft astigmatism was 5 dioptres (range, 0->20 dioptres). One or more refractive surgical procedure had been performed on 290 grafts (6 % ) followed, including suture adjustment or selective removal (32%), insertion of compression sutures (21 %), relaxing incisions and T cuts (48%), wedge resections (4%), radial keratot omy (1 %), and other refractive keratectomy includ ing by excimer laser (9%).
Immediate Reasons for Graft and Comparison of Pre
and Post-operative Acuity. Contributors to the register were requested to nominate the immediate reasons for graft. The vast majority of grafts were performed to improve visual acuity, with a small but significant number performed for the relief of pain (Table III) ; in about 14% of instances, immediate reasons for graft were multifactorial. Grafts for structural repair of the globe and for improved cosme sis were relatively rare.
In 35% of cases followed, information was available on best corrected Snellen acuity in the grafted eye, both immediately prior to the graft, and again at the time of the most recent post-operative visit (Table IV) . About four-fifths (79%) of recipi ents achieved at least one line of better acuity on the Snellen chart post-operatively; of the remainder with unchanged or worse acuity, 21 % had failed grafts. For the relatively small numbers for whom informa tion was available, 83% of those grafted only to improve visual outcome showed some improvement, compared with 70% and 63 % of those grafted only for pain relief or structural repair, respectively.
Specific Indications for Graft and Causes of Graft Failure
Keratoconus and Corneal Dystrophies: The Centre Effect. Patients grafted for keratoconus, Fuchs' dystrophy or one of the corneal dystrophies (9 lattice, 8 granular, 8 posterior polymorphous, 7 macular, 5 anterior, 2 juvenile, 1 crystalline) did well post-operatively (Fig. 4) , although it is worth noting that survival in the very small substratum (n = 8) of patients with posterior polymorphous dystrophy (80% at 5 years) was more akin to the survival rate for Fuchs' dystrophy (76% at 5 years) than for keratoconus (97% at 5 years). Graft survival as a function of individual contributor has always shown great variation within the database, 1 . 2 a reflection to some extent of the varying indications for graft within individual practices. Survival curves stratified for keratoconus or for other indications for graft for the 20 ophthalmologists contributing the largest numbers (range 41-499) of records with follow-up to the register are shown in Fig. 5a and 5b: the curves are tightly clustered for keratoconus (although there are significant differences in out come, p = 0.00003), but show enormous variation when other indications for graft are considered (p<0.00001).
Infections. After irreversible rejection, the sequelae
of infections (including bacterial, fungal and viral infections, and clinical entities such as endophthal mitis, suppurative keratitis, corneal abscesses includ ing stitch abscesses, and herpetic recurrences) were the most important reasons for graft failure. Of the cohort followed, 1 % had suffered at least one episode of bacterial or fungal keratitis post-graft, and 3% had had a herpetic episode in the grafted eye. Graft survival for the former group is shown in Fig. 6 : perhaps not surprisingly, outcome was poor (p<0.0000l) and infection was listed as the cause of graft failure in 45 % of the grafts that had failed. The situation with respect to herpetic disease was more complex. Kaplan-Meier survival for those with a herpetic episode post-operatively (Fig. 7a) was 41 % at 5 years, compared with 73 % in those who have not suffered such an episode (p<0.00001): 55 of 115 such grafts had failed, the majority (80%) from the sequelae of the recurrence itself, often complicated by graft rejection. Outcome for those with active herpetic disease at the time of graft, and for those with a past history of herpetic disease but without active disease at graft, is shown in Fig. 7b (p<0.00001). It seems clear that the predisposing event for failure in those without active disease at graft was actually the post-operative recurrence. Raised lOP. Glaucoma was the third most commonly listed cause of graft failure within the database. In univariate analysis, a history of raised lOP prior to graft and high lOP at graft (p<0.00001) and a rise in lOP in the follow-up period (p<0.0000l) were all significant risk factors for graft failure (Fig. 8a, b) . In those with a post-operative rise in lOP, a past history of elevated lOP had been recorded in 44%. A comparison of some facets of the stratum with elevated lOP in the follow-up, and with either failed or surviving grafts, is shown in Table V : of relevance may be the observation that less than 20% of grafts in either stratum were phakic, compared with 50% in either the total cohort followed or in the stratum without a post-operative rise in lOP. Lens status. One of the risk factors for graft failure over which the ophthalmologist has some control is lens status. Immediately prior to corneal transplanta tion, 60% of recipients were phakic, 30% were pseudophakic and 10% were aphakic; immediately after graft, the figures were 49%, 41% and 11%, respectively. These changes reflect intracapsular and extracapsular cataract extractions, and intraocular lens (IOL) insertions, removals and exchanges. We have previously shown graft survival to be significantly poorer in pseudophakic (any lens position) and aphakic recipients than in phakic recipients, and recipients with anterior chamber IOLs (considering recently inserted and long-stand ing lenses together) or anterior chamber iris-fixated lenses showed poorer graft survival than recipients with a posterior chamber lens. 7 ; Graft outcome in aphakic recipients, recipients with a sutured poster ior chamber IOL, recipients of a modern anterior chamber IOL (defined as a lens inserted at the time of graft or after graft) and, for comparative purposes, in those with an unsutured posterior chamber lens is shown in Fig. 9 . Separate comparisons indicated no significant differences in graft survival between eyes with a posterior chamber or a sutured posterior chamber lens (p = 0.89), or in eyes with a sutured posterior chamber lens or a modern anterior chamber lens (p = 0.434), although graft survival was higher in the former group. However, aphakic patients did show significantly worse graft survival than those with a modern anterior chamber lens (p = 0.022) or a sutured posterior chamber lens (p = 0.0012).
We have found no differences in overall visual outcome (as measured by Snellen acuity) between recipients with sutured posterior chamber IOLs or modern anterior chamber IOLs (p = 0.459), but aphakic patients had poorer Snellen acuities than those with a sutured posterior chamber IOL (p = 0.0031) or a modern anterior chamber IOL (p = 0.0007). However, there may have been less cystoid macular oedema in the aphakic patients (Table VI) .
No difference in graft survival (p = 0.995), K readings (p = 0.371) or overall Snellen acuity (p = 0.479) was apparent between recipients who had undergone a triple procedure, as compared with a staged procedure. Anisometropia in the two groups was 1.4% and 1.2%, respectively.
DISCUSSION
Comparison of Corneal Graft Survival with Survival of Other Types of Graft
Within the large, multicentre series, 1 year and 5 year Kaplan-Meier graft survival in a cohort of 4499 corneal allografts was 91 % and 72%. For compar ison, survival of renal allografts in several large studies has been reported as 81-86% at 1 year 8 , 9 and 62% at 5 years, 9 and of liver recipients (not grafts) as 79% at 1 year and 69% at 5 years. IO Interestingly, the survival of most vascularised organ grafts has shown a very considerable improvement over the last [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] years: 9 -11 renal graft survival in one large series, for example, improved from 54% at 5 years in 1971 to 82% in 1986. 9 Results of liver transplantation have improved from a 1 year patient survival of 10% prior to 1975, to 77% in 199i I largely because of increased graft survival; such improvements are widely believed to reflect improvements in manage ment and, in particular, improved immunosuppres sion.
It is difficult to establish whether corneal graft survival has improved at the same rate over the same time-frame, because there are relatively few early papers which provide Kaplan-Meier survival curve analysis of graft outcome. One such is the seminal early work of Batchelor and colleagues in 1976, 1 2 who reported 1 year survival of 57% and 2 year survival of 50% in a cohort of 200 cases, all of which were HLA typed. Any apparent improvement in survival rates may, however, be illusory: the 1976 cohort included a relatively high number of high-risk cases, of which 40% were regrafts and 71 % had evidence of corneal vascularisation at graft, com pared with an 18% regraft rate and 35% with evidence of vascularisation in our own series.
One obvious difference between the practice of corneal transplantation and that of essential organ transplantation over the past 20 years is that those immunosuppressive agents (including cyclosporin A and FK506) that have revolutionised the outcome of the latter have not thus far found a place in corneal transplantation. Systemic cyclos R orin A does improve corneal graft outcome, 3 but may be associated with substantial risks to the recipients in the long term: conventional immunosuppressive drugs appear to increase incidence of neoplasia if given over many years, 1 4 and it is not clear how long systemic immunosuppression would have to be maintained for corneal transplantation. Most practi tioners use topical corticosteroids to reduce the incidence of corneal allograft rejection. 15 Topical cyclosporin A is almost certainly less effective than are topical corticosteroids, probably because of the extremely hydrophobic nature of the drug. Sys temic 16 and local 17 admininstration of FK506 look promising in animal models of penetrating kerato plasty, but have yet to be tested clinically.
Prospects for Expert Intervention to Alter Graft Outcome
Graft survival is very dependent upon the initial indication for graft and there are a limited number of areas where positive intervention or appropriate decision-making by the ophthalmologist can affect outcome. In this context, it is appropriate to emphasise that one relevant decision is whether to perform the graft in the first place. Patient satisfac tion post-operatively is correlated with graft survival and achievement of a better visual acuity in the graft than in the contralateral eye, 18 and in cases other than keratoconus or corneal dystrophy it may be preferable not to undertake surgery if there is good existing vision in the other eye. The spread of results obtained by individual surgeons is probably a partial reflection of acceptance of differing sets of indica tions for graft. The rates of corneal transplantation per head of population vary widely in different countries; 19 not all the variation reflects inadequate donor supply. Thus, for example, approximately the same number of corneal grafts per year are performed in Australia as in the United Kingdom, but the latter has about three times the population of the former. A high graft rate may not always be correlated with good outcome.
Of the three most commonly reported reasons for graft failure -specifically, rejection, infection and glaucoma -there may be little that the ophthalmol ogist can do, once the graft has been performed, other than to treat any complications promptly. However, for the subset of recipients with a history of herpes simplex virus infection, the use of prophylactic systemic acyclovir, zo or possibly topical acyclovir? l to reduce the incidence of recurrences clearly merits consideration, given that herpetic recurrence is so strongly associated with graft failure in this and other studies. 2 1 Control of lens status in corneal graft recipients may be one area where deliberate decision-making is possible. Insertion of an unsutured posterior cham ber lens is clearly the procedure of choice after cataract extraction, but where this is not possible, the decision as to whether to insert a sutured posterior chamber lens, a flexible loop anterior chamber lens or to leave the eye aphakic, is more difficult. As a group, aphakic patients exhibit significantly poorer graft survival and Snellen acuity than do those with a sutured posterior chamber or modern anterior chamber lens, but may suffer less cystoid macular oedema. Iris-fixated anterior chamber lenses are associated with very poor graft survival. The
prevalence of cystoid macular oedema observed in grafted eyes with a sutured posterior chamber lens in this series was higher than that reported in a smaller cohort elsewhere, z 2 and approximately the same as in others studies.2 3 ,2 4 Schein and colleagues2 S have recently suggested that better results are obtained with iris fixation of posterior chamber implants compared with trans scleral fixation in patients with corneal grafts: we are unable to compare their results with our own data, because we did not collect information on the method of fixation of these implants.
Why Measure Outcome?
Amongst the transplantation community at large, corneal transplantation continues to maintain an enviable reputation for success. Whether this reputation is entirely warranted is, perhaps, ques tionable. Continuous assessment of the actualities of graft and visual outcome after corneal transplanta tion is plainly of more than academic interest. Should such outcomes be invariably excellent, then a disinterested observer might reasonably ask whether scarce research resources might not more profitably be transferred to other branches of ophthalmic practice, or to other areas of transplanta tion. Should such outcomes be less than perfect (as is of course the case in virtually all of medical practice), then a disinterested observer might wish to investi gate the extent and nature of the problems, on the basis that such information should allow the accurate and ethical counselling of patients prior to graft, the identification of cases in which latitude for alter native approaches to clinical decision-making exists, and the prioritisation of future research efforts.
How Successful is Corneal Transplantation?
In answer to the question 'How successful is corneal transplantation?', we can say that in a large cohort of patients, grafted for a wide variety of indications by a large number of ophthalmologists operating under different circumstances, the 5 year graft survival will be approximately 70%. Half the recipients are likely to achieve good best corrected Snellen acuity from their graft (and about four-fifths will show at least one line of improvement on the Snellen chart), whereas 1 in 5 will achieve less than 6/60. The median degree of post-operative astigmatism is 5 dioptres. For the 20% of patients who see poorly, approximately half will have a failed graft or will have suffered a complication of the graft, whilst 40% will have an unrelated co-morbidity in the grafted eye. Many of the co-morbidities affecting visual potential will have been present but unrecognised before graft, because the posterior segment was unable to be visualised adequately in the presence of corneal opacity. Bearing in mind that at least 78% of grafts are performed primarily for improved visual acuity and that for a further 14 % improved acuity is one of multiple reasons for graft, the level of co morbidities in the cohort is a serious problem influencing outcome for the patient. Whereas graft outcome in some subgroups of patients is truly excellent when measured by any yardstick, this is not the case in a substantial number of others.
A subset of the data presented in Table VI have been presented elsewhere in preliminary form. 7
